Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia

被引：0
|
作者：
Brown, Brianne [1 ]
Turkoz, Ibrahim [2 ]
Mancevski, Branislav [3 ]
Mathews, Maju [4 ]
机构：
[1] Janssen Sci Affairs LLC, Sci Affairs, Titusville, NJ USA
[2] Janssen Res & Dev LLC, Biostat, Titusville, NJ USA
[3] Janssen Sci Affairs LLC, Clin Dev, Titusville, NJ USA
[4] Janssen Res & Dev LLC, Global Med Affairs, Titusville, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
Long-acting injectable; Paliperidone palmitate; Duration of illness;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
607
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF PALIPERIDONE PALMITATE LONG-ACTING INJECTABLE THERAPY BY DURATION OF ILLNESS IN PATIENTS WITH SCHIZOPHRENIA
    Brown, B.
    Turkoz, I.
    Mancevski, B.
    Mathews, M.
    Reeve-Parker, K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 161 - 161
  • [2] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 198 - 198
  • [3] Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration
    Kim, Seoyoung
    Kim, SuYoun
    Koh, MinJung
    Choi, GumJee
    Kim, Jung-Jin
    Paik, In-Ho
    Kim, Seung-Hyun
    Choi, Yong-Sung
    Lee, Yohan
    Suh, Jaewon
    Takeuchi, Hiroyoshi
    Uchida, Hiroyuki
    Kim, Euitae
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (01)
  • [4] Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    EARLY INTERVENTION IN PSYCHIATRY, 2020, 14 (04) : 428 - 438
  • [5] A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
    Li, Huafang
    Rui, Qing
    Ning, Xiaoping
    Xu, Haiyan
    Gu, Niufan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1002 - 1008
  • [6] Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia
    Lin, Jia-Hong
    Tsai, Tsung-Huang
    Lee, Chia-Shun
    Yang, Ya-Hui
    Chen, Kuang-Peng
    Tung, Chun-Liong
    Tsai, Jui-Hsiu
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (08): : 829 - 830
  • [7] A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
    Fleischhacker, W. Wolfgang
    Gopal, Srihari
    Lane, Rosanne
    Gassmann-Mayer, Cristiana
    Lim, Pilar
    Hough, David
    Remmerie, Bart
    Eerdekens, Marielle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 107 - 118
  • [8] Effect of long-acting injections of paliperidone palmitate on clinical and functional outcomes in patients with schizophrenia based on illness duration
    Kim, Seoyoung
    Kim, Su Youn
    Koh, Min Jung
    Choi, Gum Jee
    Kim, Euitae
    ASIA-PACIFIC PSYCHIATRY, 2021, 13
  • [9] EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
    Kim, Seoyoung
    Kim, Su Youn
    Koh, Min Jung
    Choi, Gum Jee
    Kim, Euitae
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S115 - S116
  • [10] Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
    Alphs, Larry
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Ma, Yi-Wen
    Sliwa, Jennifer Kern
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1029 - 1042
12345